Form 4 Tracker
James Brian Windsor

Director, President and Chief Executive Officer · 1 filing · Latest: Apr 30, 2026

Rein Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RNTX
James Brian WindsorDirector, President and Chief Executive OfficerApr 30, 2026
Purchase
$1.0025,000$25.0K27,046